Skip to main content

Claudio Faria, PharmD, MPH

Director of Health Economics and
Outcomes Research
Eisai Inc
Woodcliff Lake, NJ

Director of Health Economics and Outcomes Research
Eisai Inc, Woodcliff Lake, NJ

Authored Items
Patient Preferences and Treatment Adherence Among Women Diagnosed with Metastatic Breast Cancer
Albert Tzeel, MD, MHSA, CPE, FAAPL, Marco daCosta DiBonaventura, PhD, Ronda Copher, PhD, Enrique Basurto, MSc, Claudio Faria, PharmD, MPH, Rose Lorenzo, BA
October 2014 Vol 7, No 7 in Original Research
The Impact of 5-HT3RA Use on Cost and Utilization in Patients with Chemotherapy- Induced Nausea and Vomiting: Systematic Review of the Literature
Michael S. Broder, MD, MSHS, Atheer A. Kaddis, PharmD, Claudio Faria, PharmD, MPH, Annette Powers, PharmD, MBA, Jehangeer Sunderji, MD, Dasha Cherepanov, PhD
May 2014 Vol 7, No 3 in Practice Management
Outcomes Associated with 5-HT3-RA Therapy Selection in Patients with Chemotherapy-Induced Nausea and Vomiting: A Retrospective Claims Analysis
Claudio Faria, PharmD, MPH, Curtis Wander, PharmD, Xuan Li, MS, Norman Nagl, PhD, Ali McBride, PharmD, MS
January/February 2014 Vol 7, No 1 in Original Research
Hematologic Complications, Healthcare Utilization, and Costs in Commercially Insured Patients with Myelodysplastic Syndrome Receiving Supportive Care
Annette Powers, PharmD, MBA, Claudio Faria, PharmD, MPH, Eunice Chang, PhD, Dasha Cherepanov, PhD, Jeffrey A. Bourret, PharmD
November/December 2012 Vol 5, No 7 in Practice Management
Last modified: March 12, 2014